← All trials
NCT04671355
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 4, 2021
- Primary completion
- Dec 22, 2021
- Completion date
- Feb 18, 2022
- First posted
- Dec 17, 2020
- Last posted
- Oct 8, 2021
- Enrollment
- —
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- ChiesiLead sponsor
- University of Central LancashireOverall official - principal investigator
- University of DundeeStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.